Data show that simufilam reduced seizure activity in a preclinical mouse model Presentation also highlights favorable human safety data fro ...

Removing 10 per cent of a patient’s blood before major liver surgery and giving it back afterwards reduced transfusions by ...

Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...

The Launch-HTN trial is the largest trial of an aldosterone synthase inhibitor completed in participants with uncontrolled or treatment resistant hypertension – – Lorundrostat 50 mg once daily ...

Clinical trials are an essential step in medical science; they are the key. They serve to answer questions about the safety ...

Perfuse Therapeutics is conducting trials for the treatment for glaucoma and diabetic retinopathy, aiming to restore vision ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

Iya Khalil, PhD, discusses Merck & Co.’s approach to artificial intelligence (AI), and success in applying the technology, ...

This is a useful study in the role of CHI3L1 in Kupffer cells, the macrophages of the liver, showing that CHI3L1 alters glucose regulation in obesity. Specifically, Chi3l1 protects glucose-dependent ...

Anaphylm's FDA approval process is a major catalyst, with a PDUFA date set for January 31, 2026. Find out why Aquestive ...